Investigating the connection between gut health and brain function in aging and neurodegenerative diseases
Official title: Role of the Gut-microbiota on Ageing and Neurodegeneration: a Clinical and Brain Imaging Study
Run by IRCCS San Camillo, Venezia, Italy · NCT05934188 · Data updated 2026-11-12
This study is trying to see how changes in gut health might affect brain function in older adults and those with diseases like Alzheimer's and Parkinson's.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 90 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | IRCCS San Camillo, Venezia, Italy Academic / other |
| Locations | 3 sites (Venice-Lido, Venice and 2 other locations) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | January 9, 2026 |
| Trial ID | NCT05934188 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy individuals aged 20-50 or 60-90, as well as patients with prodromal Alzheimer's Disease, Parkinson's Disease, or relapsing-remitting Multiple Sclerosis.
✕Probably not a fit
Patients with significant neurological disorders other than the specified conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore how changes in gut microbiota may influence brain structure and function during aging and in neurodegenerative diseases such as Alzheimer's, Parkinson's, and Multiple Sclerosis. By recruiting both healthy individuals and patients with specific conditions, the study will utilize advanced MRI techniques alongside biological assessments to identify potential biomarkers linked to cognitive decline. The research focuses on understanding the gut-brain axis and its role in neurodegeneration, with the goal of characterizing unique microbiota profiles associated with different disorders.
Why it matters
Potential benefit: If successful, this study could lead to the identification of early biomarkers for neurodegenerative diseases, potentially improving diagnosis and treatment strategies.
How similar studies have gone: While the gut-brain axis is a growing area of interest, this specific approach to characterizing microbiota in relation to neurodegenerative diseases is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA: Healthy Young and Old Subjects: * 20-50 or 60-90 years old * Cognitively healthy (Mini-Mental State examination ≥ 26) * Absence of significant neurological disorders Patients with prodromal Alzheimer's Disease: * Subjective cognitive complaint (corroborated by the informant) * Episodic memory deficit on neuropsychological testing * Clinical Dementia Rating = 0.5 * Mini-Mental State Examination (MMSE) \> 23 * Independently functioning in activities of daily living Patients with Parkinson's Disease: * Recent diagnosis of Parkinson's Disease * Mild-moderate score at the Unified Parkinson's Disease Rating Scale (UPDRS) * Cognitively healthy (Mini-Mental State examination ≥ 26) * In case of taking medications for Parkinson's Disease: stable dosage for at least 6 months Patients with Multiple Sclerosis: * Recent diagnosis of relapsing-remitting Multiple Sclerosis * Expanded Disability Status Scale score ≤ 4.0 * Cognitively healthy (Mini-Mental State examination ≥ 26) * In case of taking medications for Multiple Sclerosis: stable dosage for at least 6 months. EXCLUSION CRITERIA: For both healthy participants and patients: * Contraindications to magnetic resonance imaging (metal implant in body, known claustrophobia, pacemakers) * Severe comorbidities * Antibiotics treatments over the last 3 months
Where it's running
-
IRCCS San Camillo
Venice-Lido, Venice, Italy Recruiting -
IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli
Brescia, Italy Recruiting -
Università Ca' Foscari Venezia
Venice, Italy Recruiting
Study contacts
- Principal investigator: Nicola Filippini — IRCCS San Camillo, Venezia, Italy
- Study coordinator: Nicola Filippini
- Email: nicola.filippini@hsancamillo.it
- Phone: +39 041 2207304
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Early detection of neuropathologies affecting drivers
This project tests whether simple clinical and motor/cognitive tests can spot early signs of multiple sclerosis or Parkinson's disease that affect people who drive.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
-
Motor learning with physical activity and advanced devices in healthy people and movement disorders
This study tests whether combining traditional physical activity with advanced devices and immersive therapy helps improve motor skills and functional recovery in healthy individuals and people with movement disorders.
-
Telehealth rehabilitation for neurodegenerative diseases
This study is testing if online rehabilitation programs can help people with Parkinson's Disease and Multiple Sclerosis feel better compared to traditional education methods.
-
Digital app for monitoring speech and health in neurodegenerative conditions
This study is testing a digital app that records and analyzes speech to see if it can help monitor and detect neurodegenerative conditions like dementia and Parkinson's disease in both patients and healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.